Breaking News

Thermo Fisher to Invest $82.5M in Manufacturing Facility Expansion

Expanded St. Louis area facility will add 169 new jobs to manufacture biologic drug substance products.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Thermo Fisher Scientific has unveiled plans to invest $82.5 million to expand operations and create 169 new jobs at its biologic drug substance manufacturing facility in St. Louis County, according to The St. Louis Economic Development Partnership, the Missouri Department of Economic Development and Ameren Missouri. The expanded facility will manufacture biologic drug substance products that treat a variety of chronic health conditions including cancers and other life-threatening diseases as wel...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters